|
G |
A2m |
alpha-2-macroglobulin |
decreases expression |
ISO |
potassium bromate results in decreased expression of A2M mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases activity |
EXP |
[potassium bromate co-treated with Caffeine] results in increased activity of ACHE protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of ACHE protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ACHE protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ACHE protein] |
CTD |
PMID:37865952 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ada |
adenosine deaminase |
multiple interactions increases activity |
EXP |
[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of ADA protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ADA protein] |
CTD |
PMID:37865952 |
|
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
EXP |
potassium bromate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP |
potassium bromate results in increased phosphorylation of AKT1 protein Squalene inhibits the reaction [potassium bromate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:33219891 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
potassium bromate results in increased expression of APEX1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
potassium bromate results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Areg |
amphiregulin |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
affects expression |
ISO |
potassium bromate affects the expression of ASNS mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of ATF3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATM mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of ATP2B3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
potassium bromate results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
potassium bromate results in increased expression of BAX mRNA potassium bromate results in increased expression of BAX protein Squalene promotes the reaction [potassium bromate results in increased expression of BAX protein] |
CTD |
PMID:30559759 PMID:33219891 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of BCL2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of BCL2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Blnk |
B-cell linker |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BLNK mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmf |
Bcl2 modifying factor |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BMF mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
ISO |
potassium bromate results in increased expression of BRCA1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of CA3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car6 |
carbonic anhydrase 6 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of CASP3 protein Squalene promotes the reaction [potassium bromate results in increased expression of CASP3 protein] |
CTD |
PMID:33219891 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases activity multiple interactions increases activity |
ISO EXP |
potassium bromate results in decreased activity of CAT protein Arbutin inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Squalene inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of CAT protein] potassium bromate results in increased activity of CAT protein vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:26296324 PMID:27074584 PMID:33219891 PMID:36284482 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of CCL20 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions increases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CCNB1 protein] |
CTD |
PMID:20067818 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccno |
cyclin O |
decreases expression |
ISO |
potassium bromate results in decreased expression of CCNO mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 2:44,630,873...44,633,912
Ensembl chr 2:44,626,369...44,633,914
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
increases expression |
EXP |
potassium bromate results in increased expression of CDHR1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases phosphorylation |
ISO |
potassium bromate results in increased phosphorylation of CDK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions affects expression affects methylation |
ISO EXP |
potassium bromate results in increased expression of CDKN1A mRNA; potassium bromate results in increased expression of CDKN1A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Azacitidine inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; trichostatin A inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] potassium bromate affects the expression of CDKN1A mRNA; potassium bromate affects the expression of CDKN1A protein potassium bromate affects the methylation of CDKN1A gene |
CTD |
PMID:20067818 PMID:23588252 PMID:23811332 PMID:25015661 PMID:30008028 PMID:30559759 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cfd |
complement factor D |
decreases expression |
EXP |
potassium bromate results in decreased expression of CFD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
potassium bromate results in increased expression of CHAC1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Cldn2 |
claudin 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CLDN2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
potassium bromate results in increased expression of CLU protein |
CTD |
PMID:23159986 PMID:23588252 PMID:23811332 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Coch |
cochlin |
decreases expression |
EXP |
potassium bromate results in decreased expression of COCH mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
EXP |
potassium bromate results in increased expression of COMT mRNA |
CTD |
PMID:23588252 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
increases expression |
EXP |
potassium bromate results in increased expression of CSRP3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cth |
cystathionine gamma-lyase |
increases methylation |
ISO |
potassium bromate results in increased methylation of CTH promoter |
CTD |
PMID:30559759 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
decreases expression increases expression |
EXP |
potassium bromate results in decreased expression of CYP2C7 mRNA potassium bromate results in increased expression of CYP2C7 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:237,332,641...237,388,714
Ensembl chr 1:237,332,659...237,388,709
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
increases expression |
ISO |
potassium bromate results in increased expression of DDB2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
potassium bromate results in increased expression of DDIT3 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dsc1 |
desmocollin 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
|
|
G |
Dusp2 |
dual specificity phosphatase 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of DUSP2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
|
|
G |
Egr4 |
early growth response 4 |
multiple interactions affects expression |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
ISO |
potassium bromate results in decreased expression of ERCC4 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369 Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
affects response to substance multiple interactions |
ISO |
ERCC6 protein affects the susceptibility to potassium bromate veliparib promotes the reaction [ERCC6 protein affects the susceptibility to potassium bromate] |
CTD |
PMID:25136123 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
potassium bromate results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
potassium bromate results in increased expression of FAS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbxo22 |
F-box protein 22 |
increases expression |
ISO |
potassium bromate results in increased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of FEN1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgb |
fibrinogen beta chain |
increases expression |
EXP |
potassium bromate results in increased expression of FGB mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgl2 |
fibrinogen-like 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of FGL2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fry |
FRY microtubule binding protein |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
potassium bromate results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fzd2 |
frizzled class receptor 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions decreases activity |
EXP |
Taurine inhibits the reaction [potassium bromate results in decreased activity of G6PD protein] |
CTD |
PMID:25213677 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
potassium bromate results in increased expression of GADD45A mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression increases methylation |
ISO |
potassium bromate results in increased expression of GCLM mRNA potassium bromate results in increased methylation of GCLM promoter |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
potassium bromate results in increased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
potassium bromate results in increased expression of GPR87 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of GPT protein Squalene inhibits the reaction [potassium bromate results in increased activity of GPT protein] |
CTD |
PMID:33219891 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grifin |
galectin-related inter-fiber protein |
decreases expression |
EXP |
potassium bromate results in decreased expression of GRIFIN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity multiple interactions |
ISO EXP |
potassium bromate results in decreased activity of GSR protein Squalene inhibits the reaction [potassium bromate results in decreased activity of GSR protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of GSR protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:33219891 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of GSTA5 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO EXP |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] potassium bromate results in increased phosphorylation of H2AX protein Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein]; trichostatin A inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein] |
CTD |
PMID:25015661 PMID:25693136 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression |
EXP |
potassium bromate results in increased expression of HAVCR1 mRNA; potassium bromate results in increased expression of HAVCR1 protein |
CTD |
PMID:23588252 PMID:23811332 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA] |
CTD |
PMID:25618551 PMID:30008028 PMID:30559759 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression decreases expression |
ISO |
potassium bromate results in increased expression of HNF4A mRNA potassium bromate results in decreased expression of HNF4A mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hp |
haptoglobin |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of HP mRNA [potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of HPRT1 gene |
CTD |
PMID:19853637 PMID:22539617 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
increases expression |
EXP |
potassium bromate results in increased expression of IGFBP1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IKZF2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IL18R1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of IL1B mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA] |
CTD |
PMID:23588252 PMID:26296324 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il24 |
interleukin 24 |
increases expression |
EXP |
potassium bromate results in increased expression of IL24 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of IL6 mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of KIRREL3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 8:32,865,779...33,407,555
Ensembl chr 8:32,862,776...33,405,676
|
|
G |
Klf15 |
KLF transcription factor 15 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of KLF15 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lgals12 |
galectin 12 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:204,832,065...204,842,759
Ensembl chr 1:204,832,065...204,842,759
|
|
G |
Lig3 |
DNA ligase 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of LIG3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:20067818 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
ISO |
potassium bromate results in increased expression of MDM2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
potassium bromate results in increased expression of ME1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med1 |
mediator complex subunit 1 |
decreases phosphorylation |
ISO |
potassium bromate results in decreased phosphorylation of MED1 protein |
CTD |
PMID:25068892 |
|
NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
|
|
G |
Mir126a |
microRNA 126a |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR126 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
|
|
G |
Mir134 |
microRNA 134 |
increases expression |
ISO |
potassium bromate results in increased expression of MIR134 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:128,748,908...128,748,980
|
|
G |
Mir137 |
microRNA 137 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR137 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:206,480,881...206,480,982
Ensembl chr 2:206,480,884...206,480,985
|
|
G |
Mir146b |
microRNA 146b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR146B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mir193a |
microRNA 193a |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR193A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir193b |
microRNA 193b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR193B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
|
|
G |
Mir205 |
microRNA 205 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR205 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
|
|
G |
Mir21 |
microRNA 21 |
increases expression |
ISO |
potassium bromate results in increased expression of MIR21 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir23b |
microRNA 23b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR23B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir29b1 |
microRNA 29b-1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mir322 |
microRNA 322 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR424 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,806,594...132,806,688
Ensembl chr X:132,806,594...132,806,688
|
|
G |
Mir331 |
microRNA 331 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR331 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
|
|
G |
Mir542 |
microRNA 542 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR542 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of MMP2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of MMP2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
EXP |
potassium bromate results in increased expression of MTHFD2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
potassium bromate results in decreased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mutyh |
mutY DNA glycosylase |
decreases expression |
ISO |
potassium bromate results in decreased expression of MUTYH mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
|
|
G |
Myh1 |
myosin heavy chain 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:51,885,913...51,909,699
Ensembl chr10:51,885,913...51,946,295
|
|
G |
Myh2 |
myosin heavy chain 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MYLK3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Nebl |
nebulette |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
potassium bromate results in increased expression of NQO1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases response to substance increases response to substance |
ISO |
OGG1 gene mutant form results in decreased susceptibility to potassium bromate OGG1 protein results in increased susceptibility to potassium bromate |
CTD |
PMID:25693136 PMID:34196753 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Ostn |
osteocrin |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603
|
|
G |
Pde5a |
phosphodiesterase 5A |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of PDE5A protein [potassium bromate co-treated with Caffeine] results in increased activity of PDE5A protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of PDE5A protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of PDE5A protein]; naringin inhibits the reaction [potassium bromate results in increased activity of PDE5A protein] |
CTD |
PMID:37865952 |
|
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
decreases expression |
ISO |
potassium bromate results in decreased expression of PHGDH mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Plch2 |
phospholipase C, eta 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:165,544,209...165,613,769
Ensembl chr 5:165,544,200...165,602,356
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
ISO |
potassium bromate results in decreased expression of PNKP mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
ISO |
potassium bromate results in increased expression of PPM1D mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
decreases methylation |
ISO |
potassium bromate results in decreased methylation of PPP1R15A promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prg4 |
proteoglycan 4 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PRG4 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr13:62,487,257...62,504,657
Ensembl chr13:62,487,257...62,504,119
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of PTGS2 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA] |
CTD |
PMID:26296324 PMID:27082013 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PTPN22 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
|
|
G |
Rab3gap2 |
RAB3 GTPase activating non-catalytic protein subunit 2 |
increases expression |
EXP |
potassium bromate results in increased expression of RAB3GAP2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:96,757,430...96,828,930
Ensembl chr13:96,757,460...96,829,478
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
EXP |
Squalene inhibits the reaction [potassium bromate results in increased expression of RELA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
increases expression |
EXP |
potassium bromate results in increased expression of REN1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Retn |
resistin |
decreases expression |
EXP |
potassium bromate results in decreased expression of RETN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Robo3 |
roundabout guidance receptor 3 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of ROBO3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:37,133,542...37,151,674
Ensembl chr 8:37,133,916...37,151,315
|
|
G |
Rps27l |
ribosomal protein S27-like |
increases expression |
ISO |
potassium bromate results in increased expression of RPS27L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
potassium bromate results in increased expression of RRM2B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
increases expression |
EXP |
potassium bromate results in increased expression of S100A8 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
decreases expression |
EXP |
potassium bromate results in decreased expression of S100A9 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
potassium bromate results in decreased expression of SCD1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sertad1 |
SERTA domain containing 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Sesn1 |
sestrin 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SESN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
potassium bromate results in increased expression of SFN mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
decreases expression |
EXP |
potassium bromate results in decreased expression of SLC26A4 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc26a7 |
solute carrier family 26 member 7 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:27,884,400...28,021,865
Ensembl chr 5:27,887,042...28,021,658
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
potassium bromate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
ISO |
potassium bromate results in increased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of SLCO2B1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases activity multiple interactions decreases activity |
ISO EXP |
potassium bromate results in increased activity of SOD1 protein Arbutin inhibits the reaction [potassium bromate results in decreased activity of SOD1 protein] |
CTD |
PMID:22012894 PMID:36284482 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] |
CTD |
PMID:25618551 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spata22 |
spermatogenesis associated 22 |
decreases expression |
EXP |
potassium bromate results in decreased expression of SPATA22 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP ISO |
potassium bromate results in increased expression of SPP1 mRNA; potassium bromate results in increased expression of SPP1 protein |
CTD |
PMID:23588252 PMID:23811332 PMID:30008028 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SQSTM1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SRXN1 mRNA |
CTD |
PMID:22003191 PMID:30008028 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases expression |
EXP |
potassium bromate results in increased expression of SULT2A1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tigar |
TP53 induced glycolysis regulatory phosphatase |
increases expression |
ISO |
potassium bromate results in increased expression of TIGAR mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:159,927,136...159,946,077
Ensembl chr 4:159,927,139...159,946,029 Ensembl chr 6:159,927,139...159,946,029
|
|
G |
Tk1 |
thymidine kinase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of TK1 gene |
CTD |
PMID:19853637 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tmem163 |
transmembrane protein 163 |
decreases expression |
EXP |
potassium bromate results in decreased expression of TMEM163 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
increases expression |
ISO |
potassium bromate results in increased expression of TNFSF9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Tns1 |
tensin 1 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
|
|
G |
Top3b |
DNA topoisomerase III beta |
decreases expression |
ISO |
potassium bromate results in decreased expression of TOP3B mRNA |
CTD |
PMID:22539617 |
|
NCBI chr11:84,097,018...84,125,474
Ensembl chr11:84,097,026...84,125,392
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases phosphorylation |
ISO EXP |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein] |
CTD |
PMID:20067818 PMID:25015661 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
increases methylation increases expression |
ISO |
potassium bromate results in increased methylation of TP53INP1 promoter potassium bromate results in increased expression of TP53INP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
increases expression |
ISO |
potassium bromate results in increased expression of TRIAP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
EXP ISO |
potassium bromate results in increased expression of TRIB3 mRNA |
CTD |
PMID:23588252 PMID:30008028 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Ubd |
ubiquitin D |
increases expression |
EXP |
potassium bromate results in increased expression of UBD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
EXP |
Squalene inhibits the reaction [potassium bromate results in increased expression of VEGFA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vit |
vitrin |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of VIT mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:16,445,966...16,565,644
Ensembl chr 6:16,445,955...16,565,665
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of WARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
|
|
G |
Wfdc17 |
WAP four-disulfide core domain 17 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:68,561,954...68,562,801
Ensembl chr10:68,561,954...68,562,801
|
|
G |
Xdh |
xanthine dehydrogenase |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of XDH protein Taurine inhibits the reaction [potassium bromate results in increased activity of XDH protein] |
CTD |
PMID:25213677 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of XRCC3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions increases response to substance |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HCAR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SAA3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] |
CTD |
PMID:25693136 PMID:27082013 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
increases expression |
ISO |
potassium bromate results in increased expression of ZMAT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
|
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[sodium bromate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|